Anzeige
Mehr »
Freitag, 26.09.2025 - Börsentäglich über 12.000 News
Geheime Börsenchance: Ist das die bedeutendste Kupferentdeckung Kanadas?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40UHG | ISIN: US7389201077 | Ticker-Symbol:
NASDAQ
25.09.25 | 22:00
0,378 US-Dollar
-6,39 % -0,026
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ASPIRE BIOPHARMA HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
ASPIRE BIOPHARMA HOLDINGS INC 5-Tage-Chart

Aktuelle News zur ASPIRE BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ASPIRE BIOPHARMA Aktie jetzt für 0€ handeln
18.09.Aspire Biopharma files to sell 147.18M shares of common stock for holders4
18.09.Aspire Biopharma Holdings, Inc. - S-1, General form for registration of securities1
17.09.Aspire Biopharma Holdings, Inc.: Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB Sublingual Caffeine Pre-Workout Product211BUZZ BOMB engages three specialized fitness influencers to grow the brandhttps://www.instagram.com/bobbymaximus/https://www.instagram.com/midwest_kong/https://www.instagram.com/ifbbpro_moose_the_stallion/The...
► Artikel lesen
16.09.Aspire Biopharma secures initial order for preworkout supplement, part of agreement with SupraNatural1
16.09.Aspire Biopharma Holdings, Inc.: Aspire Biopharma Announces Initial Production Order of Two Million Servings of BUZZ BOMB Pre-Workout Supplement209Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ...
► Artikel lesen
03.09.Aspire Biopharma: Sublinguales Aspirin hemmt Blutgerinnung in Rekordzeit2
03.09.Aspire Biopharma Holdings, Inc.: Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction283Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosingTxB2 is a biomarker indicating aspirin's effect on platelet aggregation...
► Artikel lesen
22.08.Aspire Biopharma schließt Kaufvertrag für Schuldverschreibungen über 9,7 Mio. US-Dollar ab4
22.08.Aspire Biopharma Holdings, Inc. - 8-K, Current Report2
18.08.Aspire Biopharma Holdings, Inc.: Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction477According to the NIH, Acute myocardial infarction (AMI) is a major cause of death, affecting nearly 3 million Americans each year and resulting in over a million deathsTrial demonstrates dramatically...
► Artikel lesen
14.08.Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20175ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology...
► Artikel lesen
13.08.Aspire Biopharma Holdings, Inc. - 10-Q, Quarterly Report1
13.08.Aspire Biopharma Holdings, Inc. - 10-Q/A, Quarterly Report2
13.08.Aspire Biopharma Holdings, Inc.: Aspire Biopharma Successfully Launches BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World334BUZZ BOMB is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential30,000 BUZZ BOMB sample...
► Artikel lesen
31.07.Aspire Biopharma startet Direktvertrieb für sublinguales Koffein-Supplement2
31.07.Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement351First sublingual pre-workout single-serving supplement that delivers 50mg of caffeine rapidly to the body, is now available to order via Aspire's new direct-to-consumer shopping experience ESTERO, FL...
► Artikel lesen
31.07.Aspire Biopharma names new executive chair4
31.07.Aspire Biopharma Holdings, Inc. Announces CEO Transition470Kraig Higginson, Current Chairman of the Board, Appointed Interim CEO ESTERO, FL / ACCESS Newswire / July 30, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
► Artikel lesen
30.07.Aspire Biopharma Holdings, Inc. - 8-K, Current Report1
25.07.Aspire Biopharma's BUZZ BOMB Shows Promising Initial Feedback3
Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1